Deepti Jain is Director at TREACE MEDICAL CONCEPTS, INC. (TMCI). They have made 1 open-market trade across 1 company since 2021, most recently 2026-05-19.
CIK 0001840203
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $113K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TMCI | BUY | 2024-05-10 | 2024-05-13 | $4.50 | $113K | -1.0% | +19.3% | +11.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.